BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33043837)

  • 41. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
    Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
    Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
    Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
    Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.
    Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P
    Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
    Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
    J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
    Yuan S; Pan Q; Fu C; Bi Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
    Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
    Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.
    Takeuchi I; Takaha N; Nakamura T; Hongo F; Mikami K; Kamoi K; Okihara K; Kawauchi A; Miki T
    Prostate; 2012 Jul; 72(10):1124-32. PubMed ID: 22213442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
    Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
    Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
    Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
    Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
    Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1.
    Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
    Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice.
    Gerlini R; Amendola E; Conte A; Valente V; Tornincasa M; Credendino SC; Cammarota F; Gentile C; Di Guida L; Paladino S; De Vita G; Fusco A; Pierantoni GM
    Cell Death Dis; 2019 Oct; 10(10):747. PubMed ID: 31582725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
    Han X; Cao Y; Wang K; Zhu G
    Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
    Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
    PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hmga1 is required for normal sperm development.
    Liu J; Schiltz JF; Ashar HR; Chada KK
    Mol Reprod Dev; 2003 Sep; 66(1):81-9. PubMed ID: 12874803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas.
    Pierantoni GM; Battista S; Pentimalli F; Fedele M; Visone R; Federico A; Santoro M; Viglietto G; Fusco A
    Carcinogenesis; 2003 Dec; 24(12):1861-9. PubMed ID: 12970064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
    Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
    Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.